Terlipressin Given As I.V. Boluses Versus Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00742690
Recruitment Status : Unknown
Verified October 2014 by University of Padova.
Recruitment status was:  Recruiting
First Posted : August 28, 2008
Last Update Posted : October 15, 2014
Information provided by:
University of Padova